This website uses its own and third-party cookies in order to improve the browsing experience. If you continue browsing you will be accepting expressly the use of these cookies. You can get more information on our Cookies policy page.



OSASEN´s new biosensor for lactose intolerance diagnosis.

“Estrategia Empresarial” has recently published the news of the Point of Care (PoC) system, based on biosensors, developed by OSASEN for the diagnosis of Hypolactasia (lactose intolerance) for the Spanish company Venter Pharma.
The point of Care system is undergoing validation. It facilitates the use of LacTEST, a VENTER PHARMA´s patented diagnostic drug for the diagnosis of Hypolactasia, or intestinal lactase deficiency, which causes lactose intolerance. The test has other applications in clinical gastroenterology.

See more